Arkolith/Insider Trading/VIR/Form 4

SVF Endurance (Cayman) Ltd

10% OwnerVir Biotechnology, Inc. (VIR) · full profile →Form 4 · filed Oct 22, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$2.1M
Net Open-Market Flow
-$2.1M
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Oct 21, 2025Sell(S)110K$6.30$691K15.0M
Oct 20, 2025Sell(S)221K$6.20$1.4M15.1M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001493152-25-018917) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML